| Dual HER2 blockade slows metastatic breast cancer. | |
| | |
MedLine Citation:
|
PMID: 22585174 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Eric Bender |
Related Documents
:
|
22361774 - An unusual case of non-disseminated bladder aspergillosis in a setting of transitional ... 22281894 - Squamous cell carcinoma of the penis: clinicopathologic study of 34 cases. 17323574 - Sarcomatoid renal cell carcinoma in a binturong (arctictis binturong). 22553474 - Abc1 consensus conference - a german perspective: first international consensus confere... 11719434 - Hypermethylation in human cancers of the riz1 tumor suppressor gene, a member of a hist... 18507014 - Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer. |
Publication Detail:
|
Type: News Date: 2011-12-15 |
Journal Detail:
|
Title: Cancer discovery Volume: 2 ISSN: 2159-8290 ISO Abbreviation: Cancer Discov Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-05-15 Completed Date: 2013-01-15 Revised Date: 2013-05-08 |
Medline Journal Info:
|
Nlm Unique ID: 101561693 Medline TA: Cancer Discov Country: United States |
Other Details:
|
Languages: eng Pagination: OF4 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal, Humanized
/
administration & dosage Antineoplastic Combined Chemotherapy Protocols / therapeutic use* Breast Neoplasms / drug therapy*, enzymology, pathology Female Humans Neoplasm Metastasis Receptor, erbB-2 / antagonists & inhibitors*, metabolism Taxoids / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal, Humanized; 0/Taxoids; 114977-28-5/docetaxel; 380610-27-5/pertuzumab; EC 2.7.10.1/Receptor, erbB-2; P188ANX8CK/trastuzumab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mathematical model could aid biomarker validation.
Next Document: Biotech firms look for virtual success.